These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 10944125)
1. High-time chemotherapy or high time for low dose. Kamen BA; Rubin E; Aisner J; Glatstein E J Clin Oncol; 2000 Aug; 18(16):2935-7. PubMed ID: 10944125 [No Abstract] [Full Text] [Related]
2. [Treatment of cancer with high-dose chemotherapy and autologous stem cell transplantation]. Geisler CH; Daugaard KG; Dickmeiss E; Ifversen M; Knudsen LM Ugeskr Laeger; 2003 Dec; 165(50):4846-9. PubMed ID: 14716902 [No Abstract] [Full Text] [Related]
3. Cell cycle dependent response and combined treatment of tumor. Terasima T; Ohara H; Miyamoto T; Watanabe M; Takabe Y; Watanabe I Jpn J Antibiot; 1977 Dec; 30 Suppl():49-56. PubMed ID: 77340 [TBL] [Abstract][Full Text] [Related]
4. [High-dose chemotherapy for tumor treatment: the end of the beginning ?]. Bay JO; Blay JY Bull Cancer; 2001 Sep; 88(9):821. PubMed ID: 11604351 [No Abstract] [Full Text] [Related]
5. NCCN: High-dose chemotherapy. Applications of high-dose chemotherapy with bone marrow/stem cell support in solid tumors. Vaughan WP Cancer Control; 2001; 8(6 Suppl 2):50-2. PubMed ID: 11760558 [No Abstract] [Full Text] [Related]
6. Where next with stem-cell-supported high-dose therapy for breast cancer? Bergh J Lancet; 2000 Mar; 355(9208):944-5. PubMed ID: 10768427 [No Abstract] [Full Text] [Related]
7. High-dose chemotherapy and stem cell rescue for high-risk Ewing's family of tumors. Rosenthal J; Pawlowska AB Expert Rev Anticancer Ther; 2011 Feb; 11(2):251-62. PubMed ID: 21342043 [TBL] [Abstract][Full Text] [Related]
8. Are there still reasons to believe that high-dose chemotherapy has a role in breast cancer management? Castagna L; Martino M Bone Marrow Transplant; 2013 Feb; 48(2):305. PubMed ID: 22750999 [No Abstract] [Full Text] [Related]
9. Role of high-dose chemotherapy and autologous stem cell support in treatment of breast cancer. Myers SE; Williams SF Hematol Oncol Clin North Am; 1993 Jun; 7(3):631-45. PubMed ID: 8102137 [TBL] [Abstract][Full Text] [Related]
10. Analysis of dose-response relationships in the setting of high-dose ifosfamide, carboplatin, and etoposide and autologous hematopoietic stem cell transplantation: implications for the treatment of patients with advanced breast cancer. Perkins JB; Effenbein GJ; Fields KK Semin Oncol; 1996 Jun; 23(3 Suppl 6):42-6. PubMed ID: 8677448 [TBL] [Abstract][Full Text] [Related]
11. [Dose intensity in cancer chemotherapy (including high dose chemotherapy)]. Ariyoshi Y; Ogawa M Gan To Kagaku Ryoho; 1994 Dec; 21(16):2699-707. PubMed ID: 7993104 [TBL] [Abstract][Full Text] [Related]
12. Time-dose factors in chemotherapy: expanding the concept of dose-intensity. Dembo AJ J Clin Oncol; 1987 May; 5(5):694-6. PubMed ID: 3572462 [No Abstract] [Full Text] [Related]
14. The role of cell kinetics in cancer chemotherapy. Valeriote FA; Edelstein MB Semin Oncol; 1977 Jun; 4(2):217-26. PubMed ID: 327554 [No Abstract] [Full Text] [Related]
15. High dose therapy and autologous hematopoietic stem cell transplantation in septuagenarians with non-Hodgkin lymphoma: Feasible, but for which patients? Wildes TM; Cashen A J Geriatr Oncol; 2015 Sep; 6(5):344-5. PubMed ID: 26272671 [TBL] [Abstract][Full Text] [Related]